AAU universities conduct a majority of the federally funded university research that contributes to our economic competitiveness, health and well-being, and national security. AAU universities are growing our economy through invention and innovation while preparing the next generation of scientists and engineers for global leadership. By moving research into the marketplace AAU universities are helping to create jobs, and provide society with new medicines and technologies.
UMD geologists uncovered evidence of a section of seafloor that sank into the Earth's mantle when dinosaurs roamed the Earth; it's located off the west coast of South America in a zone known as the East Pacific Rise.
Novel research supported by NCI could lead to more specific predictive disease models
A new University of Kansas study reveals parents seeking health care information for their children trust AI more than health care professionals when the author is unknown, and parents rate AI generated text as credible, moral and trustworthy.
Hypertension and amyloid plaques can separately cause dementia. Having both increases a person’s odds of developing cognitive decline, a new study finds
Explore More: University Research
You can filter stories by the university.
A nasal spray derived from algae and a plant in the tobacco family could offer a preventive measure for COVID-19, per Pitt researchers.
Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
Armed with a rapid response research grant from the National Science Foundation, University of Oregon biologist Stilianos Louca is mining public databases for genomic and associated data being filed on the coronavirus that causes COVID-19.
UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have therapeutic value for COVID-19 patients who have developed or at high risk of developing serious lung damage from SARS-CoV-2 infections.
Joshua Barocas, a physician-scientist working at Boston University School of Medicine and Boston Medical Center (BMC) both researches the novel coronavirus in the lab and treats patients infected with it in the clinic.